Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Schwaab · SciRah

Researcher profile · Semantic Scholar

J. Schwaab

Share profile

J. Schwaab — researcher profile on SciRah

h-index: 35
Works: 122
Citations: 4,028

Most-cited papers

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
P. Valent, C. Akin, K. Hartmann, I. Álvarez-Twose +36 more
2021HemaSphere207 citations Open access
Semantic Scholar
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
M. Jawhar, J. Schwaab, S. Schnittger, M. Meggendorfer +13 more
2016Leukemia197 citations
Semantic Scholar
Proposed Refined Diagnostic Criteria and Classification of Eosinophil Disorders and Related Syndromes
P. Valent, A. Klion, F. Roufosse, D. Simon +19 more
2022Allergy. European Journal of Allergy and Clinical Immunology157 citations Open access
Semantic Scholar
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M. Jawhar, J. Schwaab, S. Schnittger, K. Sotlar +12 more
2015Leukemia137 citations
Semantic Scholar
Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers.
M. Jawhar, J. Schwaab, N. Naumann, H. Horny +9 more
2017Blood103 citations Open access
Semantic Scholar
MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
M. Jawhar, J. Schwaab, I. Álvarez-Twose, K. Shoumariyeh +21 more
2019Journal of Clinical Oncology94 citations Open access
Semantic Scholar
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
M. Jawhar, J. Schwaab, M. Meggendorfer, N. Naumann +10 more
2017Haematologica86 citations Open access
Semantic Scholar
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
M. Jawhar, J. Schwaab, D. Hausmann, J. Clemens +11 more
2016Leukemia78 citations Open access
Semantic Scholar
Global Classification of Mast Cell Activation Disorders An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium.
P. Valent, K. Hartmann, P. Bonadonna, Theo Gülen +28 more
2022Journal of Allergy and Clinical Immunology: In Practice70 citations Open access
Semantic Scholar
The 2014 liver ultrasound tracking benchmark
V. De Luca, T. Benz, S. Kondo, L. Konig +16 more
2015Physics in Medicine and Biology68 citations Open access
Semantic Scholar
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes
J. Schwaab, N. Naumann, J. Luebke, M. Jawhar +17 more
2020American journal of hematology/oncology67 citations Open access
Semantic Scholar
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review.
Theo Gülen, C. Akin, P. Bonadonna, F. Siebenhaar +28 more
2021Journal of Allergy and Clinical Immunology: In Practice65 citations Open access
Semantic Scholar
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.
K. Blatt, S. Cerny-Reiterer, J. Schwaab, K. Sotlar +14 more
2015Blood61 citations Open access
Semantic Scholar
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User´s Guide for Daily Clinical Practice.
P. Valent, K. Hartmann, J. Schwaab, I. Álvarez-Twose +23 more
2022Journal of Allergy and Clinical Immunology: In Practice58 citations Open access
Semantic Scholar
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase
M. Jawhar, N. Naumann, J. Schwaab, H. Baurmann +25 more
2017Annals of Hematology53 citations Open access
Semantic Scholar
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis
N. Naumann, M. Jawhar, J. Schwaab, S. Kluger +15 more
2018Genes, Chromosomes and Cancer52 citations Open access
Semantic Scholar
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.
J. Muñoz-González, I. Álvarez-Twose, M. Jara-Acevedo, R. Zanotti +32 more
2021The Lancet Haematology49 citations
Semantic Scholar
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives
P. Valent, J. O. Oude Elberink, A. Górska, Magdalena Lange +44 more
2018Journal of Allergy and Clinical Immunology: In Practice49 citations Open access
Semantic Scholar
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group.
G. Hoermann, K. Sotlar, M. Jawhar, T. Kristensen +23 more
2022Journal of Allergy and Clinical Immunology: In Practice42 citations Open access
Semantic Scholar
Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
A. Reiter, J. Gotlib, I. Álvarez-Twose, D. Radia +17 more
2022Leukemia40 citations Open access
Semantic Scholar
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry
V. Kennedy, C. Perkins, A. Reiter, M. Jawhar +51 more
2022Blood Advances40 citations Open access
Semantic Scholar
Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis
J. Lübke, N. Naumann, S. Kluger, J. Schwaab +9 more
2019Leukemia40 citations Open access
Semantic Scholar
Treatment-free remission in FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation.
G. Metzgeroth, J. Schwaab, N. Naumann, M. Jawhar +6 more
2020Blood Advances38 citations Open access
Semantic Scholar
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
P. Bonadonna, K. Brockow, M. Niedoszytko, H. Elberink +29 more
2021Journal of Allergy and Clinical Immunology: In Practice37 citations Open access
Semantic Scholar
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
H. Kluin-Nelemans, A. Reiter, A. Illerhaus, B. van Anrooij +42 more
2019Leukemia37 citations Open access
Semantic Scholar
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
G. Metzgeroth, L. Steiner, N. Naumann, J. Lübke +8 more
2023Leukemia36 citations Open access
Semantic Scholar
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
A. Reiter, J. Schwaab, D. DeAngelo, J. Gotlib +13 more
2022Blood Advances36 citations Open access
Semantic Scholar
Importance of adequate diagnostic work-up for correct diagnosis of advanced systemic mastocytosis.
J. Schwaab, Nicole Hartmann, N. Naumann, M. Jawhar +14 more
2020Journal of Allergy and Clinical Immunology: In Practice35 citations Open access
Semantic Scholar
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia‐associated myeloproliferative neoplasms
N. Naumann, J. Schwaab, G. Metzgeroth, M. Jawhar +12 more
2015Genes, Chromosomes and Cancer35 citations
Semantic Scholar
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
H. Kluin-Nelemans, M. Jawhar, A. Reiter, B. van Anrooij +43 more
2021Theranostics33 citations Open access
Semantic Scholar
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
M. Jawhar, K. Döhner, S. Kreil, J. Schwaab +22 more
2019Leukemia31 citations Open access
Semantic Scholar
Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis
J. Lübke, J. Schwaab, N. Naumann, H. Horny +11 more
2022Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
P. Valent, C. Akin, P. Bonadonna, K. Brockow +22 more
2020Journal of Allergy and Clinical Immunology28 citations Open access
Semantic Scholar
Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation
J. Schwaab, M. Jawhar, N. Naumann, A. Schmitt-Graeff +6 more
2016Annals of Hematology28 citations
Semantic Scholar
Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia
Ghaith Wedeh, S. Cerny-Reiterer, G. Eisenwort, H. Herrmann +15 more
2015Leukemia28 citations Open access
Semantic Scholar
Impact of centralized evaluation of bone marrow histology in systemic mastocytosis
M. Jawhar, J. Schwaab, H. Horny, K. Sotlar +7 more
2016European Journal of Clinical Investigation26 citations Open access
Semantic Scholar
Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
B. Nedoszytko, M. Arock, Jonathan J. Lyons, Guillaume Bachelot +10 more
2021International Journal of Molecular Sciences25 citations Open access
Semantic Scholar
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
B. Peter, Siham Bibi, G. Eisenwort, Bettina Wingelhofer +18 more
2017Leukemia23 citations Open access
Semantic Scholar
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
D. Mclornan, T. Czerw, G. Damaj, M. Ethell +17 more
2024Leukemia22 citations
Semantic Scholar
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
K. Sotlar, T. George, P. Kluin, A. Reiter +24 more
2022Journal of Allergy and Clinical Immunology: In Practice22 citations Open access
Semantic Scholar
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis proposed by the ECNM-AIM Consortium.
P. Pyatilova, C. Akin, I. Álvarez-Twose, M. Arock +28 more
2022Journal of Allergy and Clinical Immunology: In Practice21 citations Open access
Semantic Scholar
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis
P. Riffel, J. Schwaab, C. Lutz, N. Naumann +7 more
2020Journal of Cancer Research and Clinical Oncology20 citations Open access
Semantic Scholar
Identification of a Leukemia-Initiating Stem Cell in Human Mast Cell Leukemia
G. Eisenwort, I. Sadovnik, J. Schwaab, M. Jawhar +13 more
2019Leukemia20 citations Open access
Semantic Scholar
Additional Mutations in SRSF2, ASXL1 and/or RUNX1 Identify a High Risk Group of Patients with KIT D816V+ Advanced Systemic Mastocytosis
M. Jawhar, J. Schwaab, S. Schnittger, M. Meggendorfer +12 more
201519 citations
Semantic Scholar
Proposed ECNM-AIM Response Criteria in Advanced Systemic Mastocytosis.
J. Gotlib, J. Schwaab, W. Shomali, T. George +28 more
2022Journal of Allergy and Clinical Immunology: In Practice16 citations Open access
Semantic Scholar
Expression of programmed cell death ligand-1 in mastocytosis correlates with disease severity.
Anja Rabenhorst, S. Leja, J. Schwaab, M. Gehring +5 more
2016Journal of Allergy and Clinical Immunology16 citations
Semantic Scholar
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Lina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, Anna-Katharina Schruef +17 more
2023American Journal of Cancer Research15 citations
Semantic Scholar
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis
P. Riffel, M. Jawhar, Kristina Gawlik, J. Schwaab +5 more
2019Annals of Hematology15 citations
Semantic Scholar
Automated quality assessment in three-dimensional breast ultrasound images
J. Schwaab, Yago Diez, A. Oliver, R. Martí +5 more
2016Journal of Medical Imaging15 citations Open access
Semantic Scholar
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
J. Rotterdam, Margot Thiaucourt, Christel Weiss, J. Schwaab +13 more
2022Annals of Hematology13 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Jawhar×36
Invite
M. Jawhar — researcher profile on SciRah
P. Valent×32
Invite
P. Valent — researcher profile on SciRah
A. Reiter×31
Invite
A. Reiter — researcher profile on SciRah
H. Horny×28
Invite
H. Horny — researcher profile on SciRah

×23

Invite

K. Sotlar — researcher profile on SciRah

Invite

W. Sperr — researcher profile on SciRah

G. Metzgeroth×22

Invite

G. Metzgeroth — researcher profile on SciRah

A. Fabarius×20

Invite

A. Fabarius — researcher profile on SciRah

Invite

W. Hofmann — researcher profile on SciRah

Invite

J. Gotlib — researcher profile on SciRah

Invite

N. Naumann — researcher profile on SciRah

Invite

M. Arock — researcher profile on SciRah